{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T02:49:47Z","timestamp":1747190987560,"version":"3.40.5"},"reference-count":24,"publisher":"Wiley","license":[{"start":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T00:00:00Z","timestamp":1663891200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Case Reports in Infectious Diseases"],"published-print":{"date-parts":[[2022,9,23]]},"abstract":"<jats:p>Background. Mendelian susceptibility to mycobacterial diseases (MSMD) is an inborn error of immunity categorized as defects in intrinsic and innate immunity. MSMD is characterized by vulnerability to less virulent mycobacteria, such as Bacillus Calmette-Gu\u00e9rin (BCG) vaccine strains, as well as environmental mycobacteria (EM). The definitive diagnosis is made by genetic analysis. Treatments constitute antimycobacterial, interferon-gamma, surgery, and hematopoietic stem cell transplantation (HSCT), which is the only known curative treatment. The mortality rate ranges from 40% to 80% depending on the severity of the mutation. Case. A 13-year-old female patient had multiple hospital visits since the age of 6\u2009months. The most striking diagnosis was repeated mycobacterial infections. She had tuberculosis affecting lymph nodes, skin and soft tissue, bone and joints, the lungs, and epidural and paraspinal regions. She has taken all the childhood vaccines, including BCG. She has been treated four times with first-line and once with second-line antituberculosis drugs. Currently, she is on treatment for nontuberculous mycobacteria and is receiving interferon-gamma. Genetic studies showed autosomal dominant Mendelian susceptibility to mycobacterial disease due to IFNG-R1 defect. Conclusion. To the authors\u2019 knowledge, this is the first case report of Mendelian susceptibility to mycobacterial diseases secondary to interferon gamma receptor 1(IFNG-R1) defect in Ethiopia. Although it has been immensely challenging, our multidisciplinary team has learned a lot from the clinical presentation, diagnosis, and management of this child.<\/jats:p>","DOI":"10.1155\/2022\/6534009","type":"journal-article","created":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T23:05:16Z","timestamp":1663974316000},"page":"1-8","source":"Crossref","is-referenced-by-count":0,"title":["Mendelian Susceptibility to Mycobacterial Diseases (MSMD) in a 13-Year-Old Ethiopian Girl with Autosomal Dominant Interferon Gamma Receptor 1(IFN-\u03b3 R1) Defect: A Clinical Diagnostic and Treatment Challenge"],"prefix":"10.1155","volume":"2022","author":[{"given":"Netsanet Azene","family":"Gebeyehu","sequence":"first","affiliation":[{"name":"Department of Dermatology and Venereology, Addis Ababa University College of Health Sciences, Addis Ababa, Ethiopia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7391-9419","authenticated-orcid":true,"given":"Solomie Jebessa","family":"Deribessa","sequence":"additional","affiliation":[{"name":"Pediatrics Infectious Disease Specialist, Department of Pediatrics and Child Health, St.Paul\u2019s Hospital Millennium Medical College, Addis Ababa, Ethiopia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Freeman","family":"Alexandra","sequence":"additional","affiliation":[{"name":"Primary Immune Deficiency Clinic Laboratory of Clinical Immunology and Microbiology NIAID, NIH, North Bethesda, MD, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Messay Tesfaye","family":"Demissie","sequence":"additional","affiliation":[{"name":"Dermatovenerologist, Pediatric Dermatology Fellow, Addis Ababa University College of Health Sciences, Addis Ababa, Ethiopia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W","family":"Mihretu Gebre","sequence":"additional","affiliation":[{"name":"Dermatovenerologist, Photoallergologist, Addis Ababa University College of Health Sciences, Addis Ababa, Ethiopia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aklilu Melaku","family":"Gebremariam","sequence":"additional","affiliation":[{"name":"Dermatovenerologist, Dermatopathologist, Addis Ababa University College of Health Sciences, Addis Ababa, Ethiopia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dagmawit Mitiku","family":"Engliz","sequence":"additional","affiliation":[{"name":"Dermatovenerologist, Debre Birhan Specialized Hospital, Debre Birhan, Ethiopia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tizita Yosef","family":"Kidane","sequence":"additional","affiliation":[{"name":"Dermatovenerologist, Dermatosurgeon, Addis Ababa University College of Health Sciences, Addis Ababa, Ethiopia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lidya","family":"Million Bekele","sequence":"additional","affiliation":[{"name":"Pediatrics Resident, Department of Pediatrics and Child Health, St.Paul\u2019s Hospital Millennium Medical College, Addis Ababa, Ethiopia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abate Yeshidinber","family":"Weldetsadik","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care, Department of Pediatrics and Child Health, St.Paul\u2019s Hospital Millennium Medical College, Addis Ababa, Ethiopia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","reference":[{"key":"1","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-022-01289-3"},{"key":"2","doi-asserted-by":"publisher","DOI":"10.1016\/s0161-5890(02)00017-2"},{"key":"3","doi-asserted-by":"publisher","DOI":"10.1111\/imr.12032"},{"key":"4","article-title":"Histiocytosis syndromes of childhood","volume-title":"Journal of Nepal Pediatrics Society","author":"S. Ladisch","year":"2010"},{"key":"5","article-title":"Cell- mediated defense against Infection","volume-title":"Mendell, Douglas and Bennett\u2019s, Principles and Practices of Infectious Diseases","author":"T. M. Hohl","year":"2016"},{"key":"6","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.21.120601.141114"},{"key":"7","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.18.1.275"},{"issue":"2","key":"8","doi-asserted-by":"crossref","first-page":"988","DOI":"10.4049\/jimmunol.130.2.988","article-title":"Natural killer (NK) cells as a responder to interleukin 2 (IL 2). II. IL 2-induced interferon gamma production","volume":"130","author":"K. Handa","year":"1983","journal-title":"The Journal of Immunology"},{"key":"9","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2014.09.008"},{"issue":"9","key":"10","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.156.9.3321","article-title":"Salmonella typhimurium aroA- infection in gene-targeted immunodeficient mice: major role of CD4+ TCR-alpha beta cells and IFN-gamma in bacterial clearance independent of intracellular location","volume":"156","author":"J. Hess","year":"1996","journal-title":"Journal of Immunology"},{"key":"11","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.175.7.4593"},{"key":"12","doi-asserted-by":"publisher","DOI":"10.1126\/science.280.5368.1435"},{"key":"13","doi-asserted-by":"publisher","DOI":"10.1056\/nejm199612263352604"},{"key":"14","doi-asserted-by":"publisher","DOI":"10.1086\/315197"},{"key":"15","doi-asserted-by":"publisher","DOI":"10.1038\/nrg3114"},{"key":"16","doi-asserted-by":"publisher","DOI":"10.1038\/nri933"},{"volume-title":"Disorders of Phagocyte FunctionNelson Text Book of Pediatrics","year":"2016","author":"T. D. Coates","key":"17"},{"article-title":"Histiocytosis syndromes of childhood","year":"2010","author":"S. Ladisch","key":"18"},{"key":"19","doi-asserted-by":"publisher","DOI":"10.1056\/nejm199612263352602"},{"key":"20","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(04)17552-1"},{"key":"21","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000009035","article-title":"A 25-year surveillance of disseminated Bacillus Calmette\u2013Gu\u00e9rin disease treatment in children in Southern Iran","volume":"96","author":"A. Amanati","year":"2017","journal-title":"Medicine"},{"key":"22","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.63129"},{"key":"23","doi-asserted-by":"publisher","DOI":"10.3389\/conf.fimmu.2015.05.00109"},{"author":"The World Bank","key":"24","article-title":"Incidence of tuberculosis, Ethiopia 2020"}],"container-title":["Case Reports in Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/downloads.hindawi.com\/journals\/criid\/2022\/6534009.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/downloads.hindawi.com\/journals\/criid\/2022\/6534009.xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/downloads.hindawi.com\/journals\/criid\/2022\/6534009.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,20]],"date-time":"2023-02-20T09:21:18Z","timestamp":1676884878000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.hindawi.com\/journals\/criid\/2022\/6534009\/"}},"subtitle":[],"editor":[{"given":"Dawei","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2022,9,23]]},"references-count":24,"alternative-id":["6534009","6534009"],"URL":"https:\/\/doi.org\/10.1155\/2022\/6534009","relation":{},"ISSN":["2090-6633","2090-6625"],"issn-type":[{"type":"electronic","value":"2090-6633"},{"type":"print","value":"2090-6625"}],"subject":[],"published":{"date-parts":[[2022,9,23]]}}}